Switzerland Medical Device Registration Cost 2026: CH-REP Pricing Models, Flat Fee vs Hourly Billing, and 3-Year Cash Flow Comparison

How Much Does It Cost to Register a Medical Device in Switzerland in 2026?

For a single CE-marked device entering Switzerland in 2026, expect a 3-year all-in budget of roughly USD 6,000–18,000 for a Class I or IVD Class A device and USD 9,000–35,000 for a Class IIb/III or IVD Class C/D device, excluding Swissmedic government fees (themselves in flux ahead of the Swissmedic mandatory device registration deadline of July 1, 2026, when device entry into the swissdamed database becomes compulsory), Swiss importer costs, certified translations into German/French/Italian, and EU Notified Body fees for the underlying CE certificate. The wide range is not driven by Swissmedic — its current notification fee is a flat CHF 300 and the future device-registration fee is "to be determined" but expected to be modest. It is driven almost entirely by how your Swiss Authorized Representative (CH-REP) bills you.

Three pricing models dominate the CH-REP market today, and the difference between the cheapest and most expensive can exceed 4x over three years for the same scope of work:

CH-REP Pricing Model	Year 1 Cost (Class IIa, 1 device)	Year 1 Cost (Class III, 1 device)	3-Year Total (Class IIa)	3-Year Total (Class III)
Hourly billing	$5,000–$9,000	$10,000–$18,000	$11,000–$20,000	$20,000–$40,000
Registration fee + lower annual	$4,500–$8,000	$7,000–$12,000	$9,000–$18,000	$14,000–$28,000
Flat all-inclusive annual fee	$2,000–$3,000	$2,000–$3,000	$6,000–$9,000	$6,000–$9,000

CH-REP fees, not Swissmedic fees, are where Swiss budgets get blown up. Switzerland is an unusual market in this respect: because Swissmedic accepts the EU CE certificate as the conformity assessment and does not run its own dossier review, the local-rep relationship is the single largest recurring regulatory line item for any non-Swiss manufacturer. This guide is about how to use that leverage.

Skip to Your Scenario

• Single Class IIa device, pre-revenue startup: Read Scenario A first — flat fee saves $4,000–$7,000 in Year 1 cash.
• Single Class III or IVD Class D device entering Switzerland: Read Scenario B — Year 1 burden under hourly is over 60% of 3-year cost.
• Multi-device portfolio (3+ devices): Read Scenario C — tier discounts compound dramatically.
• Already have a CH-REP and want to switch: Skip to the CH-REP Switching Playbook.
• Issuing an RFP this week: Skip to the RFP Template and 8 questions to ask.
• Want to validate the numbers: Read the Named Provider RFP Comparison.

Why CH-REP Pricing Is Where Switzerland Budgets Win or Lose

Since the EU-Switzerland Mutual Recognition Agreement (MRA) lapsed for medical devices on May 26, 2021 and for IVDs on May 26, 2022, every non-Swiss manufacturer placing a device on the Swiss market must appoint a Swiss Authorized Representative (CH-REP) under MedDO Art. 51 (devices) and IvDO Art. 47 (IVDs). The CH-REP is the manufacturer's legal anchor inside Switzerland — registered in swissdamed with a CH Registration Number (CHRN), responsible for verifying ongoing MedDO/IvDO compliance, holding a copy of the technical documentation, handling vigilance correspondence with Swissmedic, and (from July 1, 2026) maintaining device registration in swissdamed.

Unlike Brazil's BRH or China's NMPA Agent, the CH-REP does not prepare the original conformity-assessment dossier. The CE technical documentation comes from the manufacturer and the EU Notified Body. The CH-REP role is purely representation: confirming documentation is in order, registering operators and devices in swissdamed, requesting Free Sale Certificates, and serving as the in-country regulatory point of contact. That representation cost is a recurring annual fee that runs as long as the device is on the Swiss market.

Three structural facts make CH-REP pricing the highest-leverage line in any Swiss budget:

• The scope of work is narrow and standardized. No dossier review, no conformity assessment — just representation, swissdamed entries, and document custody. Multiple firms perform this identical statutory role.
• CH-REP fees from major providers vary by 4-6x. There is more pricing variance per unit of regulatory work in CH-REP services than in almost any other major market.
• 2026 is a transition year. Operator registration in swissdamed has been mandatory since August 2024. Device registration becomes mandatory July 1, 2026, with a transition period through December 31, 2026. Every existing CH-REP relationship is being re-priced or re-scoped to absorb this work.

Most CH-REP pricing is not published. You have to issue an RFP, sign an NDA, and compare proposals where every firm has a different scope inclusion list. That is exactly the comparison this article is designed to short-circuit.

The Three CH-REP Pricing Models, Decoded

Model 1: Hourly billing ("charge by hour")

The default model for boutique Swiss regulatory firms and many of the consulting-led CH-REP providers based in Bern, Basel, Zurich, and Lausanne. Scope is captured in a Statement of Work; everything outside scope (including most "small" requests like a Free Sale Certificate or a swissdamed amendment) is billed at hourly rates that typically run $140–$410/hour depending on tier and seniority:

Consultant Tier	Switzerland/EU Hourly Rate (2026)	Typical Work
Tier 1 — senior MedDO/IvDO strategist	$345–$410/hr	MedDO Art. 51 / IvDO Art. 47 disputes, Swissmedic escalations, vigilance investigations
Tier 2 — regulatory specialist	$255–$305/hr	swissdamed device registration, technical documentation review, Free Sale Certificate management
Tier 3 — associate / documentation	$140–$180/hr	Translations (DE/FR/IT), CHRN administration, file maintenance

(Source: MedDeviceGuide Medical Device Regulatory Consulting Hourly Rates by Region.)

Why buyers choose hourly: flexibility, perceived control, ability to use the CH-REP only when needed.

Why hourly is bad for buyers in practice:

• No incentive to be efficient. Every hour spent on swissdamed entry, Free Sale Certificate requests, or label review is revenue.
• Surprise invoices. "Quick swissdamed cleanup" becomes 6 hours. Translation review of an updated IFU becomes 8 hours. The bill arrives 60 days after the work.
• Scope creep is invisible until it bills. A modification for the January 2025 IVD permanent simplification rule can be 2 hours or 12 — you find out after.
• Disincentive to communicate. Every email is potentially billable, so you ask fewer questions and end up with worse outcomes. In the July 2026 transition year, worse outcomes mean missed deadlines.
• Year 1 cash flow shock. First-year work (designation, mandate, swissdamed CHRN registration, device entries, translation review, baseline Free Sale Certificates) is front-loaded by definition and frequently 3–5x the steady-state annual hours.

A typical Class IIb hourly engagement for a single device runs $8,000–$15,000 in Year 1 and $3,000–$8,000/year thereafter.

Model 2: Registration fee + lower annual maintenance

The dominant model for mid-to-large CH-REP service firms today. Buyer pays a one-time setup/registration fee plus a smaller recurring annual fee, with each "extra" itemized. Public benchmarking confirms this model is currently priced at CHF 3,000–6,000 in Year 1 and somewhat less thereafter for a single device (Source: MedEnvoy and QS Engineering AG public statements, April 2026).

Typical structure:

Component	Class I / IVD Class A–B	Class IIa–IIb	Class III / IVD Class C–D
One-time CH-REP onboarding fee	$1,500–$2,500	$2,000–$3,500	$2,500–$5,000
Initial swissdamed device entry (per device)	$500–$1,500	$750–$2,000	$1,000–$3,000
Annual maintenance fee	$1,500–$3,000	$2,500–$4,500	$3,500–$6,500
Per-modification fee	$300–$1,500	$500–$2,500	$800–$4,000
Free Sale Certificate request	$200–$500 each	$200–$500 each	$200–$500 each
Vigilance/FSCA reporting	hourly	hourly	hourly
Annual technical-documentation review	$500–$1,500	$750–$2,500	$1,000–$3,500

The trap: the marketing message is "low annual fee," but Year 1 actual spend is usually $4,500–$12,000 because every CH-REP appointment triggers onboarding + swissdamed registration + initial document review + first Free Sale Certificate simultaneously.

Where this model fails buyers:

• Year 1 cash flow shock is structural. All major one-time fees fire in the same calendar year — and 2026 specifically forces a swissdamed device-entry bill on every existing client.
• Modifications are unbounded. MedDO has been updated multiple times since 2023 to track EU MDR/IVDR delegated acts. Each ordinance update plus each CE technical-file change generates 1–3 modification filings per device per year. At $500–$2,500 each, that is a $1,000–$5,000/year invisible tax.
• Free Sale Certificates scale with export needs. Some CH-REPs charge $200–$500 per CFS. A re-export hub user needing 10–30 CFSs/year pays $2,000–$15,000 in administrative fees.
• Mandatory-registration cliff. July 1, 2026 forces every existing voluntary client to file the device in swissdamed. Reg-plus-annual firms are now invoicing this as a separate event ($500–$3,000 per device on top of the existing annual fee) — exactly the kind of regulatory churn a flat fee absorbs at zero incremental cost.

Model 3: Flat all-inclusive annual fee

A newer pricing model where the CH-REP charges a single annual fee covering swissdamed registration, all modifications, all Free Sale Certificate requests, all CHRN correspondence, vigilance handoff, and all renewals. The same number every year, including across the July 2026 voluntary→mandatory transition.

Two structural advantages:

1. The fee curve is flat instead of front-loaded. Year 1 cost equals Year 2 cost equals Year 3 cost.
2. CH-REP incentives align with yours. Every additional hour the CH-REP spends is pure cost to them, so they are motivated to file cleanly and avoid Swissmedic queries.

The catch: flat-fee CH-REPs typically require a multi-year contract and exclude Swissmedic government fees, certified DE/FR/IT translations for non-Swissmedic authorities, and Swiss importer services.

This model is rare. As of April 2026, Pure Global is the only major CH-REP service provider that publishes a complete flat-fee schedule on its website (pureglobal.com/services/pricing). Pure Global delivers the CH-REP service via a sub-contracted Swiss partner — a normal and legal arrangement under MedDO Art. 51 — where the CH-REP entity is established in Switzerland and Pure Global manages the commercial relationship.

Why this guide uses Pure Global as the worked example

We use Pure Global's published CH-REP rates throughout this article because they are the only flat-fee CH-REP rates in the public domain — anyone can verify them at pureglobal.com/services/pricing. This is not an endorsement and not every reader will choose Pure Global. The published rates simply let us do an apples-to-apples cash flow comparison that would otherwise require RFPs to multiple firms operating under NDA. Industry ranges shown for hourly and front-loaded models are based on typical RFP responses, public competitor blog posts, and procurement data collected by MedDeviceGuide.

Recommended Reading

European Union Medical Device Registration Cost 2026: EC REP Pricing Models, Flat Fee vs Hourly Billing, and 3-Year Cash Flow Comparison

EU MDR / IVDR Reimbursement & Market Access2026-04-24 · 40 min read

Pure Global Switzerland CH-REP Pricing (Published, April 2026)

MD and IVD — All Classes (Single Tier)

Pure Global's published rate does not differentiate by device class. Because the CE certificate already encodes class and the CH-REP does not re-perform conformity assessment, the workload is essentially flat across Class I, IIa, IIb, III, and IVD Classes A–D. The fee scales only with the number of registrations.

Number of Registrations	MD & IVD Class	Annual Flat Fee (USD)
1	All Classes	$2,000
2	All Classes	$2,500
3	All Classes	$3,000
4	All Classes	$3,500
5	All Classes	$4,000
6+	All Classes	Custom quote

Included in the annual fee — per Pure Global's published price list ("preparation and submission of the registration, modifications, renewals, free sale certificate requests, and correspondence with authorities; based on CE reference market approval"):

• Preparation and submission of the registration — Pure Global (via its sub-contracted Swiss partner) prepares and submits the swissdamed device registration on the basis of the existing CE reference-market approval; this is the work that becomes mandatory under the July 1, 2026 swissdamed deadline
• Modifications to the registered device data — Pure Global handles modification filings; the price list does not state a numeric cap, and Pure Global has not published one, so treat "unlimited" as customary practice rather than a contractual guarantee and confirm the modification volume cap (or absence of one) in writing
• Renewals of the device registration
• Free Sale Certificate requests with Swissmedic — the price list does not state a per-year cap; confirm any annual limit in writing if you expect heavy CFS volume (re-export hubs commonly need 10+ CFSs/year)
• Correspondence with authorities on the registered devices — covers routine Swissmedic correspondence on the swissdamed entries

Inherent to the CH-REP statutory role under MedDO Art. 51 / IvDO Art. 47 (included by definition, not separately billable):

• CH-REP designation and written mandate under MedDO Art. 51 / IvDO Art. 47 — the legal anchor that allows the manufacturer to place devices on the Swiss market
• Economic-operator (CHRN) registration in swissdamed — every CH-REP is required to register itself as an economic operator and hold a CHRN before it can submit device registrations on behalf of a manufacturer
• Holding a copy of the technical documentation and making it available to Swissmedic on request — an explicit MedDO Art. 51 / IvDO Art. 47 obligation on the CH-REP
• Forwarding vigilance / FSCA notifications between the manufacturer and Swissmedic per MedDO Art. 66 / IvDO Art. 59 — routing only; preparing the manufacturer's incident analysis is not in scope
• CH-REP symbol authorization for labeling under EN ISO 15223-1 / Annex symbol requirements

Confirm scope before signing — these activities are not itemized on Pure Global's published price list, so verify in writing whether they sit inside the annual fee or are quoted separately:

• Annual technical-documentation review (a periodic review of the CE technical file beyond simple custody) — the xlsx commits to custody and registration submission, not to recurring TD review work
• MedDO / IvDO ordinance-update tracking and proactive notification when an ordinance change forces a label, IFU, or swissdamed-entry refresh
• Liechtenstein placement under the Swiss-Liechtenstein Customs Treaty (most CH-REPs cover Liechtenstein automatically, but the price list does not state this explicitly)
• Transfer-out letter and swissdamed designation relinquishment at end of contract — Pure Global's published 50% early-termination clause is buyer-friendly, but a "no separate transfer fee" commitment is not stated in the xlsx
• Swissmedic-query response time (who pays if Swissmedic queries a swissdamed entry — the xlsx covers "correspondence with authorities" generically; confirm queries are inside the annual fee, not billed at the $200/hour ad-hoc rate)
• Cantonal authority correspondence (non-Swissmedic) — confirm whether this is treated as "correspondence with authorities" under the annual fee or as ad-hoc work

Explicitly excluded — separately quoted on Pure Global's consulting menu: Ad-hoc support for Switzerland is billed at $200/hour for any out-of-scope work.

Not included (third-party / pass-through): Swissmedic government fees — currently a CHF 300 custom-made device notification and a TBD per-device swissdamed registration fee that becomes effective with the July 2026 mandatory device-registration deadline (Swissmedic has confirmed there will be a fee but had not published the schedule as of the April 2026 capture date); Swiss importer services (separate operator role under MedDO Art. 53); certified DE/FR/IT translations for cantonal authorities; EU Notified Body fees; clinical evaluation work.

Service-delivery model — disclose this to your QMS and procurement team: Pure Global is not itself a Swiss-resident entity. Its CH-REP service is delivered through a sub-contracted Swiss partner that holds the swissdamed CHRN and the CH-REP designation. The buyer's commercial contract and invoice are with Pure Global; the regulatory designation in swissdamed is held by the partner. This is a normal and legal arrangement under MedDO Art. 51, but it should be disclosed in writing alongside the partner's identity, ISO 13485 status, and Swissmedic inspection history before signing.

Contract Terms

• Standard contract: 3 years.
• Annual contract option: available, but the first-year fee is increased by 50%.
• Early termination: allowed at any time with a 50% payoff of the remaining contract value.
• Ad-hoc consulting (non-clients or out-of-scope work): $200/hour.

(Source: pureglobal.com/services/pricing, captured April 2026. Switzerland CH-REP price list version 2.0, last updated 2025-12-04.)

3-Year Cash Flow: Side-by-Side Comparison

The pricing model only matters because of cash timing. The following scenarios show the same scope of work — one device, CH-REP only, Swissmedic government fees excluded — under each of the three models. Numbers are illustrative and based on the ranges given above.

Scope assumption. The Pure Global flat-fee column in these scenarios assumes that swissdamed device registration submission, modifications, renewals, Free Sale Certificate requests, and Swissmedic correspondence are inside the annual fee — these items are explicitly listed in Pure Global's published price-list comments. The scenarios additionally assume that annual technical-documentation review (a recurring review beyond simple custody) and MedDO/IvDO ordinance-update tracking are absorbed inside the same annual fee because of the CH-REP's statutory custody and compliance-verification role; neither is itemized on Pure Global's published price list, so confirm in writing before signing. Out-of-scope work is billed at Pure Global's published $200/hour ad-hoc rate. Government fees (CHF 300 custom-made notification; the TBD swissdamed device registration fee that activates with the July 2026 mandatory deadline) are passed through at cost in every scenario.

Scenario A: Single Class IIa Device, 3-Year Total

Cost Bucket	Hourly Billing	Registration + Annual	Flat Fee (Pure Global)
Year 1 onboarding + swissdamed entry	$5,500 (28 hrs × ~$200)	$4,500	$2,000
Year 1 CFSs + 1 modification	$1,500 (8 hrs)	$1,000	included
Year 1 total	$7,000	$5,500	$2,000
Year 2 maintenance + 2 mods + 3 CFSs	$3,500	$4,200	$2,000
Year 3 maintenance + 2 mods + 3 CFSs	$3,500	$4,200	$2,000
3-Year Total	$14,000	$13,900	$6,000
Year 1 share of 3-year spend	50%	40%	33%

The Year 1 burden under flat fee is $2,000 vs $7,000 under hourly — same regulatory output. For an early-stage MedTech preparing for the July 2026 swissdamed deadline, that $5,000 in retained Year 1 cash is often the difference between confirmed Swiss launch and a 12-month deferral. Over 3 years, flat fee is 2.3x cheaper than hourly and 2.3x cheaper than reg-plus-annual.

Scenario B: Single Class III Device, 3-Year Total

Cost Bucket	Hourly Billing	Registration + Annual	Flat Fee (Pure Global)
Year 1 onboarding + swissdamed entry + tech-doc review	$11,000 (40 hrs × $275 blended)	$8,000 ($3,500 onboarding + $2,500 swissdamed entry + $2,000 tech-doc review)	$2,000
Year 1 Free Sale Certificates + 2 modifications	$2,500	$2,000	included
Year 1 total	$13,500	$10,000	$2,000
Year 2 maintenance + 3 mods + Swissmedic vigilance	$5,500 (22 hrs)	$5,500 ($4,500 annual + $1,000 mods)	$2,000
Year 3 maintenance + 3 mods + Swissmedic vigilance	$5,500 (22 hrs)	$5,500 ($4,500 annual + $1,000 mods)	$2,000
3-Year Total	$24,500	$21,000	$6,000
Year 1 share of 3-year spend	55%	48%	33%

Under hourly, 55% of the 3-year CH-REP cost lands in Year 1 — the worst possible time for a Swiss entrant who has not yet earned Swiss revenue and is paying simultaneously for EU Notified Body annual surveillance, swissdamed registration costs, and DE/FR/IT label localization. Flat fee distributes the same scope of work evenly, freeing roughly $11,500 of Year 1 working capital for testing, clinical evidence, or sales hires.

Scenario C: 5-Device Portfolio (Mixed Classes)

A typical portfolio: 2 Class IIa, 2 Class IIb, 1 Class III.

Cost Bucket	Hourly Billing	Registration + Annual	Flat Fee (Pure Global)
Year 1 total	$35,000–$55,000	$22,000–$38,000	$4,000 (5-device tier)
Year 2	$15,000–$25,000	$14,000–$22,000	$4,000
Year 3	$15,000–$25,000	$14,000–$22,000	$4,000
3-Year Total	$65,000–$105,000	$50,000–$82,000	$12,000

A 5-device Swiss portfolio at Pure Global's published rate ($4,000/year, $12,000 over 3 years) costs less than the first year alone of a single Class III device under hourly billing. The marginal CH-REP work for an additional device under the flat-fee tier is $500–$1,000/year — below the cost of issuing two Free Sale Certificates under most reg-plus-annual contracts.

What "All-Inclusive" Actually Means: Scope Checklist

When CH-REP proposals all claim to "include everything," the differences are in the fine print. Use this checklist to compare proposals line by line.

Service Item	Hourly (typical)	Reg + Annual (typical)	Flat Fee — Pure Global
CH-REP designation under MedDO Art. 51 / IvDO Art. 47	hourly	one-time onboarding	inherent to statutory role
swissdamed CHRN economic-operator registration	hourly	included	inherent to statutory role
swissdamed device registration (mandatory July 2026)	hourly	per-device fee	included (published — "preparation and submission of the registration")
Modifications to registered device data	hourly per modification	$300–$2,500 each	included (published — "modifications"; volume cap not stated, confirm in writing)
Free Sale Certificate request to Swissmedic	hourly	$200–$500 each	included (published — "free sale certificate requests"; per-year cap not stated, confirm in writing)
Swissmedic correspondence on registered devices	hourly	sometimes included	included (published — "correspondence with authorities")
Renewal of device registration	hourly	extra	included (published — "renewals")
Technical documentation custody (Swissmedic on-request retrieval)	hourly	sometimes included	inherent to statutory role (MedDO Art. 51)
Vigilance / FSCA forwarding to Swissmedic	hourly	hourly above scope	inherent to statutory role (MedDO Art. 66 / IvDO Art. 59)
Annual technical-documentation review (recurring TD review)	hourly	$500–$3,500	confirm with provider (not itemized on price list)
MedDO/IvDO ordinance-update tracking	hourly	sometimes included	confirm with provider (not itemized)
Swissmedic query response on a swissdamed entry	hourly	sometimes included	confirm with provider (price list says "correspondence with authorities" — confirm queries are not billed at $200/hr ad-hoc)
Cantonal authority correspondence (non-Swissmedic)	hourly	hourly	separate — $200/hr (ad-hoc consulting menu)
Liechtenstein placement (Customs Treaty)	included or hourly	included	confirm with provider (not itemized on price list)
Transfer-out letter at end of contract	hourly	sometimes a fee	confirm with provider (50% early-termination payoff is published; no separate "transfer fee" not explicitly published)
Out-of-scope work / ad-hoc consulting	included	hourly	separate — $200/hr (consulting menu)
Custom-made device notification (CHF 300/device)	passed through	passed through	passed through at cost (no markup)
Swissmedic swissdamed device registration fee (TBD, July 2026+)	passed through	passed through	passed through at cost (no markup; fee schedule TBD)
Swiss importer services	not in CH-REP scope	not in CH-REP scope	not included
DE/FR/IT translations for non-Swissmedic authorities	hourly	extra	not included

The scope items that quietly drive Year-2-and-beyond cost overruns under the hourly and reg-plus-annual models are: modifications, Free Sale Certificates, and annual technical-documentation reviews. Together they generally account for 50–75% of post-Year-1 CH-REP spend. Whether they are inside or outside the flat fee is the single biggest line in any side-by-side comparison.

Recommended Reading

Brazil Medical Device Registration Cost 2026: BRH Pricing Models, Flat Fee vs Hourly Billing, and 3-Year Cash Flow Comparison

ANVISA Reimbursement & Market Access2026-04-24 · 34 min read

What 2026 Switzerland Regulatory Churn Costs Under Each Pricing Model

Switzerland's regulatory environment between 2021 and 2026 has been more active than in any equivalent period since the original LHand 2002 device decree — a direct consequence of the MRA collapse and the resulting need to build a parallel Swiss framework. Each rule change forces existing CH-REP relationships to file modifications, generate swissdamed entries, repackage technical files, or update labelling. Under hourly billing or reg-plus-annual, every one of those filings is a billable event. Under flat fee, they are not. This is the line item that competitors do not bring up during the sales call, and it is where the case for flat fee gets quantitatively compelling.

Modification and Filing Volume from 2022–2026 Switzerland Rules

The cumulative regulatory load a typical device on the Swiss market has absorbed in the four years since the MRA collapse:

Regulation / Event	Effective	Filing Triggered	Filings per Device
MRA collapse (medical devices)	May 26, 2021	CH-REP appointment, mandate, label revision	1–2
MRA collapse (IVDs)	May 26, 2022	CH-REP appointment for IVDs, IvDO compliance check	1 (IVDs)
MedDO/IvDO updates 2023	2023	EU MDR/IVDR delegated act tracking	1
swissdamed economic-operator registration	Aug 2024	CHRN registration	1–2
MedDO/IvDO updates 2024	2024	Custom-made route; vigilance forms	1–2
IVD permanent labeling simplification	Jan 1, 2025	Label/IFU revision (non-self-test IVDs)	1 (IVDs)
swissdamed device registration voluntary	Aug 2025	Optional pre-July-2026 entry	0–1
MedDO/IvDO updates 2025	2025	EU MDR/IVDR alignment; updated Mar 2026 vigilance forms	1–2
swissdamed device registration mandatory	July 1, 2026	Mandatory swissdamed entry per device	1 per device
Periodic CE technical-file updates	Ongoing	CH-REP must hold updated copy + correspond with Swissmedic	1–2/year

Aggregated, a typical Class IIb device has filed 4–7 cumulative regulatory events since 2022. IVDs are at 3–6 events. July 2026 adds one more guaranteed event per device.

What That Modification Volume Costs You

Pricing Model	Per-Filing Cost	4-Year Cost (Class IIb, 6 filings)	4-Year Cost (Class III, 8 filings)
Hourly billing (3–6 hrs × $275 blended)	$825–$1,650	$4,950–$9,900	$6,600–$13,200
Reg fee + annual ($300–$2,500 each)	$300–$2,500	$1,800–$15,000	$2,400–$20,000
Pure Global flat fee	included	$0 incremental	$0 incremental

Under hourly or reg-plus-annual, regulatory churn becomes a hidden tax that scales with how active the regulator is — not with how active you are. Switzerland is currently in the most active regulatory transition window of its post-MRA history. That is exactly the wrong environment in which to sign a 3-year hourly contract.

What Switzerland Has Queued for 2026–2028

The pipeline already in consultation or scheduled, each of which will trigger fresh CH-REP work:

• swissdamed mandatory device registration: July 1, 2026 with transition through December 31, 2026. Every device on the Swiss market needs a swissdamed entry by that date, including legacy devices and devices subject to vigilance actions (no transition extension for vigilance-flagged devices).
• First Swissmedic invoicing for swissdamed device registration: January 2027. Fee schedule still TBD as of April 2026.
• Continued MedDO/IvDO ordinance updates tracking EU MDR/IVDR delegated acts — at least annually through 2028.
• Potential UK-Switzerland MRA progress would create new in-country rep route options.
• swissdamed module expansion — Certificates, Market Surveillance, Clinical, Vigilance modules planned in line with EUDAMED.

A reasonable 2026–2028 forecast for an existing Class IIb device is 3–5 additional filings. At hourly rates that is another $2,500–$8,000 per device. Under flat fee, $0. For a 5-device portfolio, the difference is roughly $12,500–$40,000 in net Switzerland P&L impact over 2026–2028.

Why the July 2026 Transition Is a Flat-Fee Tipping Point

The voluntary→mandatory swissdamed deadline generates a one-time forced filing for every existing CH-REP relationship at the same moment. Reg-plus-annual firms are pricing the swissdamed device entry at $500–$3,000 per device on top of the existing annual fee. For a manufacturer on flat fee, the July 2026 entry is included — zero incremental invoice. Flat fee is the only model that absorbs this transition without re-priced invoices.

When Flat Fee Wins, and When It Does Not

Flat fee is not universally the best choice. The decision framework:

Flat fee usually wins when:

• You expect to keep the device on the Swiss market for ≥3 years.
• You have ≥1 device that is commercially active in Switzerland (because even a single device with ongoing Free Sale Certificate requests, modifications, and the mandatory July 2026 swissdamed entry breaks even quickly under flat fee).
• You have ≥2 devices in your Swiss portfolio (tier discounts compound — going from 1 to 2 devices is only $500/year more under Pure Global's published rate).
• You are pre-revenue or capital-constrained and want to smooth cash outflow across the July 2026 mandatory-registration deadline.
• You do not want to micromanage hourly billing or audit consultant invoices in a foreign jurisdiction.
• You expect to need Free Sale Certificates regularly (e.g., re-export hub use).

Hourly billing might still win when:

• You are doing a one-time discovery exercise (e.g., a CH-REP feasibility assessment) and do not yet have a registration to maintain.
• You have a single Class I device that you will distribute via a Swiss-resident manufacturer relationship (in which case CH-REP is not needed).
• You need ad-hoc strategic counsel (e.g., responding to a Swissmedic vigilance investigation) outside an existing CH-REP relationship.
• Your CE certificate is about to lapse and you may withdraw from Switzerland — short-horizon CH-REP coverage is cheaper hourly.

Registration-fee-plus-annual is rarely the optimal choice on TCO grounds. It typically lands between hourly and flat fee on cost while preserving the cash flow problem of Year 1 front-loading and exposing the buyer to per-modification and per-CFS billing through the July 2026 mandatory transition.

Government Fees: A Quick Reference

CH-REP service fees are excluded from Swissmedic government fees in every model. For completeness, the official 2026 Swissmedic fees relevant to CH-REP work are:

Filing	Government Fee
Custom-made device notification (per device)	CHF 300
Administrative surcharge (incomplete/corrected applications)	CHF 200/hour
Class I MD device notification (Swiss manufacturers only, pre-July-2026)	CHF 300 per notification
swissdamed device registration (mandatory July 1, 2026)	TBD — first invoicing January 2027
Fee-reduction application	Available (form published March 2026)

The TBD swissdamed registration fee is the single most important pricing-uncertainty risk in 2026 Swiss budgets. Pure Global's flat fee insulates the buyer from the fee-schedule uncertainty entirely: regardless of what Swissmedic finalizes for the swissdamed registration fee schedule, the flat-fee CH-REP service captures all CH-REP-side filing work at a known annual rate. The government fee itself is passed through at cost to the manufacturer.

For a complete breakdown of the Swiss regulatory framework, swissdamed timeline, MedDO/IvDO classification, and post-market obligations, see Switzerland Swissmedic Medical Device Registration Guide (2026).

Recommended Reading

Colombia Medical Device Registration Cost 2026: INVIMA Representative Pricing Models, Flat Fee vs Hourly Billing, and 3-Year Cash Flow Comparison

Regulatory Reimbursement & Market Access2026-04-24 · 42 min read

8 Questions to Ask Any CH-REP Before You Sign

This checklist works regardless of which CH-REP you are evaluating. Demand explicit, written answers before signing — not verbal assurances during the sales call.

1. Is the fee fixed for the contract term, or subject to annual escalation? If escalation: capped at what (Swiss CPI? EU CPI? uncapped? "market rate"?). Many Swiss CH-REPs assert annual fee increases as a default.
2. Is the July 2026 swissdamed mandatory device registration included in the existing annual fee, or charged as a separate line item? This is the single most expensive 2026 CH-REP question, because the answer differs by 4–8x across providers.
3. How many Free Sale Certificates are included per year? "Unlimited" should be in writing. "Reasonable use" or "typical use" is a red flag — re-export hubs commonly need 10+ CFSs annually.
4. How many modifications are included per year? Is the cap per device or per portfolio? What counts as a modification (CE technical-file update? labeling? IFU? manufacturer-name change? Notified Body change?).
5. What is the per-hour rate for out-of-scope work? Some firms advertise low base fees and charge $400+/hour for anything outside scope. Pure Global's published rate is $200/hour.
6. Who pays if Swissmedic queries a swissdamed entry or requests technical documentation? Under hourly, you do. Under flat fee, the CH-REP should. Confirm in writing.
7. What are the termination terms? Pure Global publishes 50% payoff of remaining contract value. Many competitors require full payoff or 12-month notice. This matters more than the headline price.
8. Will the CH-REP provide a transfer letter and surrender CHRN designation at no cost if you decide to leave? Some firms hold the swissdamed designation hostage. Get the transfer-out commitment in writing before signing.

If a CH-REP refuses to answer any of these in writing, that is the answer to the question.

CH-REP Switching Playbook: How to Leave Without Getting Trapped

The single most expensive mistake in CH-REP selection is signing a contract you cannot exit affordably. Many foreign manufacturers discover, 18 months in, that their CH-REP is mediocre but switching costs more than staying. This section is the operational playbook competitors avoid publishing.

The Swissmedic / swissdamed CH-REP Change Procedure

Switching CH-REP is mechanically simpler than ANVISA Transferência de Titularidade or NMPA agent change because there is no underlying Swissmedic dossier to transfer — only the swissdamed designation. The mechanic:

Step	Who Performs	Typical Duration	Notes
1. Manufacturer issues new written mandate to incoming CH-REP	Manufacturer + new CH-REP	1–2 weeks	Written mandate per MedDO Art. 51
2. Outgoing CH-REP provides transfer letter / acknowledgement	Outgoing CH-REP	0 days to 6 months	This is the choke point. Some firms drag this through the full notice period.
3. Incoming CH-REP updates swissdamed designation	New CH-REP	1–2 weeks swissdamed processing	Faster than EUDAMED
4. Outgoing CH-REP cancels its swissdamed association	Outgoing CH-REP	1–4 weeks	Mostly mechanical
5. Updated CHRN association reflected in swissdamed	Swissmedic / swissdamed	Real-time once submitted	Public via swissdamed Actor module
6. Update label/IFU/accompanying-document references to new CH-REP	Manufacturer	1–6 months	Labels can be updated at next print run; not a stop-sale event
Total realistic timeline		30–90 days end-to-end	Faster if outgoing CH-REP cooperates

The bottleneck is almost always step 2. Swissmedic / swissdamed cannot reliably process a CH-REP change without the outgoing CH-REP relinquishing its designation. A CH-REP that wants to retain you can effectively delay your departure by stalling on this single document.

Contract Termination Clauses: How They Actually Compare

The termination clause buried in your CH-REP agreement is often more economically consequential than the headline annual fee. Common terms in the market:

Termination Term	Typical Industry Practice	Pure Global Published Term
Notice period required	6–12 months	None — termination effective on contract anniversary
Payoff of remaining contract value on early exit	100% of remaining contract	50% payoff of remaining contract
Transfer letter delivery commitment	Within "reasonable time" (undefined)	Standard contract term
Separate "transfer fee" charged at exit	$1,000–$3,000 typical	None
Right to withhold swissdamed designation	Sometimes asserted	Explicitly waived in published terms
Right to publish termination on swissdamed proactively	Sometimes used as leverage	Not used as leverage

If you sign a typical industry CH-REP contract today that requires 12 months notice plus 100% payoff of remaining term, the effective cost of switching mid-contract on a $4,000/year deal is $4,000 (notice fees) + $8,000 (remaining 2-year payoff) + $2,000 (transfer fee) = $14,000 before you pay the new CH-REP a cent. That is more than 2 years of flat-fee under Pure Global's published 2-device rate.

The Distributor-as-CH-REP Lock-In Trap

The most common trap for first-time Switzerland entrants: letting the in-country distributor double as the CH-REP. Up front this looks efficient — one relationship, no separate retainer, often "free" as part of the commercial deal. The economic reality is harsher.

If your distributor holds the CH-REP designation:

• Switching distributors requires a CH-REP designation change, creating 30–90 days of designation-update risk and label inconsistency exposure.
• The distributor has implicit veto power. Want to add a second importer? They can refuse parallel documentation. Want to renegotiate margins? They can drag the transfer letter.
• The "free CH-REP" is priced into the distributor margin. Industry practice is 5–15% commercial markup. For a $2M/year Switzerland business, that is $100,000–$300,000/year in implicit CH-REP cost.
• MedDO/IvDO accountability is muddied. Regulatory non-compliance found during a Swissmedic inspection of the distributor can put your designation in jeopardy.

The right structure: an independent CH-REP holds the designation, and one or more distributors are importers under MedDO Art. 53 with their own CHRN. Switching distributors becomes a commercial decision, not a regulatory one.

Clean Switching: 7-Step Sequencing

1. Sign the new CH-REP first, conditional on successful swissdamed designation update.
2. Generate a fresh written MedDO Art. 51 / IvDO Art. 47 mandate in parallel, counter-signed before notifying the outgoing CH-REP.
3. Time the notice letter to land 30 days before the contract anniversary to minimize early-termination cost.
4. Cite specific contract clauses in your termination letter (transfer letter and swissdamed designation-relinquishment commitments). Many CH-REPs respond to legal pressure but not commercial requests.
5. Update the swissdamed designation the day you receive the transfer acknowledgement.
6. Hold label coverage continuous — the incoming CH-REP's name must appear on the label, IFU, or accompanying document (delivery note, invoice, customs document). Phase the label change in at the next print run.
7. Confirm CHRN credentials and swissdamed device-registration transfer — device entries are tied to the CH-REP CHRN and require re-association under the new CHRN.

A well-executed switch costs $1,000–$3,000 and 30–90 days. A poorly executed one spanning the July 2026 deadline can cost a year of market access. Negotiate the termination clause hardest before signing.

Named Provider RFP Comparison: Pure Global vs Typical Competitor Quotes

We modeled the same scope of work — a single Class IIb device with a valid EU MDR CE certificate, 3-year CH-REP relationship, all standard inclusions — under three pricing structures. Pure Global uses the published rate. Composite quotes use the midpoint of typical Swiss CH-REP RFP responses and public competitor pricing statements: MedEnvoy's blog ($2,000–$8,000 typical annual range), QS Engineering AG's published CHF 1,500/year base plus per-product fees, and various consultancies' "$3,000–$6,000 first year, less thereafter" framing.

Same Scope, Three Models, 3-Year Total

Scope baseline: 1 Class IIb medical device with valid EU MDR CE certificate, 3-year CH-REP contract, 3 Free Sale Certificates/year, 1–2 modifications/year, July 2026 mandatory swissdamed device registration in scope.

Line Item	Pure Global (Flat Fee)	Composite Hourly Quote	Composite Reg+Annual Quote
Year 1 — CH-REP onboarding & mandate	$2,000 (annual fee)	$4,000 (16 hrs × $250 blended)	$3,000 ($2,500 onboarding + $500 admin)
Year 1 — swissdamed CHRN economic-operator entry	included	$700 (3 hrs T2)	included
Year 1 — swissdamed device registration (mandatory July 2026)	included	$1,400 (6 hrs T2)	$1,500 (per-device entry fee)
Year 1 — annual technical-doc review	included	$900 (4 hrs T2)	$1,500 separately quoted
Year 1 — 3 Free Sale Certificates	included, unlimited	$750 (5 hrs T3)	$750 (3 × $250)
Year 1 — 1 modification	included	$550 (2 hrs T2)	$1,000
Year 1 total	$2,000	$8,300	$7,750
Year 2 — annual maintenance	$2,000	$4,500 (18 hrs blended)	$4,500 base
Year 2 — 2 modifications + 3 CFSs	included	$2,200	$1,750
Year 3 — annual maintenance	$2,000	$4,500	$4,500
Year 3 — 2 modifications + 3 CFSs	included	$2,200	$1,750
3-Year Total	$6,000	$21,700	$20,250

(Pure Global rates verified at pureglobal.com/services/pricing. Composite ranges drawn from typical Swiss CH-REP RFP responses observed by MedDeviceGuide and public competitor pricing statements; individual firm numbers vary.)

Key Takeaways from the Comparison

• Pure Global at the published rate is 3.6x cheaper than the composite hourly quote over 3 years, and 3.4x cheaper than the composite reg+annual quote.
• The cost gap widens further in 2026 specifically because of the July 2026 swissdamed mandatory deadline — a one-time forced filing that reg-plus-annual firms are invoicing as a separate line item ($500–$3,000) and that flat fee absorbs at zero incremental cost.
• The hourly model is the most punishing in Year 1 ($8,300 vs $2,000) because every CH-REP onboarding task is billed and the mandatory swissdamed registration adds a fresh hour bucket.
• The reg-plus-annual model has the widest bracket because providers vary enormously on whether the July 2026 swissdamed entry, modifications, and Free Sale Certificates are inside the annual fee or billed separately. Read every "included" claim line by line.
• The flat-fee model is insulated from invoice variance and from Swissmedic's own TBD government-fee uncertainty. The only variable you control is whether you signed for 1, 2, 3, 4, or 5 devices — everything else is a fixed CH-REP cost.

Why Composite Instead of Named Competitors

No other major CH-REP provider publishes a complete tiered fee schedule. Every firm's quote varies by negotiation, scope inclusion, and volume — single-firm naming gives a misleadingly precise picture. The point of this analysis is the structural difference between pricing models, not which specific competitor is best. If you want firm-specific pricing, issue your own RFP using the template below.

Recommended Reading

Clinical Equivalence Assessment Under EU MDR: Technical, Biological, and Clinical Equivalence

Clinical Evidence EU MDR / IVDR2026-04-24 · 12 min read

CH-REP RFP Template Copy and Paste

CH-REP RFPs come back in different formats with different scope inclusion lists, making side-by-side comparison nearly impossible. Use the template below to force every firm into the same structure.

---

Subject: Request for Proposal — Swiss Authorized Representative (CH-REP) Services for [Manufacturer Name]

Dear [Provider],

[Manufacturer Name] is evaluating Swiss Authorized Representative service providers for our medical device portfolio entering or maintaining presence in the Swiss market under MedDO and IvDO. We are issuing this RFP to [N] firms and request a written proposal by [date].

Portfolio Scope

#	Device Name	MD Class / IVD Class	EU MDR/IVDR CE Certificate Status	Currently CH-REP-Designated?	Anticipated Modifications/Year
1	[Device A]	[I / IIa / IIb / III or IVD A/B/C/D]	[Issued — NB#]	[Yes / No]	[N]
2	[Device B]

Contract Term: We anticipate a [3-year / 5-year] CH-REP relationship.

Required Pricing Format

Please provide pricing in the following table for each year of the contract term. Indicate explicitly whether each line item is included in the base fee or billed separately, and if separately, on what unit basis.

Service Item	Year 1 Cost	Year 2 Cost	Year 3 Cost	Inclusion (Y/N)	Per-Unit Rate if Separate
CH-REP designation under MedDO Art. 51 / IvDO Art. 47
swissdamed CHRN economic-operator registration
swissdamed device registration (mandatory July 1, 2026) — per device
Annual technical-documentation review and custody
Modifications to swissdamed device data — please state limit
Free Sale Certificate requests — please state limit per year
Vigilance / FSCA forwarding to Swissmedic
Renewal of device registrations
Liechtenstein placement under Customs Treaty
Out-of-scope hourly rate (T1 / T2 / T3)

Required Disclosures

1. Annual fee escalation clause — fixed, Swiss CPI-linked, EU CPI-linked, or uncapped?
2. Notice period required for non-renewal at end of term.
3. Early termination payoff — what percentage of remaining contract value?
4. Transfer letter and swissdamed designation-relinquishment commitment in days from termination notice.
5. Any separate "transfer fee" charged at exit — yes/no, amount.
6. Confirmation that Swissmedic government fees (CHF 300 custom-made notification, future swissdamed registration fee) are passed through at cost without markup.
7. Whether the firm holds the CH-REP designation directly or via a sub-contracted Swiss-resident partner. Either is legal under MedDO; we want it disclosed in writing.
8. Confirmation of ISO 13485 certification of the CH-REP entity (where applicable).
9. Confirmation that the firm has been inspected by Swissmedic as a CH-REP and the most recent inspection outcome.

Evaluation Criteria

We will evaluate proposals on (in order): (1) total 3-year cost at our forecast scope, (2) inclusion completeness — fewer separately-billed line items is better, (3) termination clause flexibility, (4) treatment of the July 2026 swissdamed mandatory deadline, (5) responsiveness during this RFP, (6) Swissmedic inspection track record (please attach 2–3 references).

Please respond by [date] to [contact email].

Best regards,

[Your Name]

[Your Title], [Manufacturer Name]

---

This template forces every CH-REP to price the same scope. The line items where firms diverge most — the July 2026 swissdamed entry, modifications, Free Sale Certificates, technical-documentation review, and termination clauses — are exactly the items the template makes them disclose explicitly. After three to five proposals come back in this format, the right answer for your portfolio is usually obvious within an hour of comparing.

Frequently Asked Questions

Is a Swiss Authorized Representative the same as a Swiss importer?

No. The CH-REP is the manufacturer's regulatory representative under MedDO Art. 51 / IvDO Art. 47. The Swiss importer is a separate economic operator role under MedDO Art. 53, registered in swissdamed with its own CHRN, responsible for placing devices from a third country onto the Swiss market. The same firm can play both roles, but combining them creates lock-in if the commercial relationship sours. See Switzerland Swissmedic Medical Device Registration Guide.

Can my EU EC-REP also serve as my Swiss CH-REP?

No. The CH-REP must be established in Switzerland (or Liechtenstein under the Customs Treaty). Some regulatory service providers offer both EC-REP and CH-REP services under separate contracts using separate Swiss-resident entities.

Why does Pure Global use a sub-contracted Swiss partner for CH-REP services?

The CH-REP role legally requires a Swiss-resident (or Liechtenstein-resident) entity. Pure Global delivers its CH-REP service through a contracted Swiss partner that holds the swissdamed CHRN and CH-REP designation. This is a normal and legal arrangement under MedDO Art. 51. The buyer's contract is with Pure Global; the regulatory designation in swissdamed is held by the partner.

How long does a CH-REP transition take if I want to switch?

Typically 30–90 days end-to-end. Pure Global's 50% remaining-contract-value early-termination clause is among the more buyer-friendly in the industry — many CH-REPs require full remaining contract payoff plus 6–12 months of notice.

Does the CH-REP pay Swissmedic government fees on my behalf?

The CH-REP submits filings on your behalf; Swissmedic fees (CHF 300 custom-made notification; future TBD swissdamed registration fee) are reimbursed at cost. Reputable CH-REPs do not mark up government fees.

What happens if Swissmedic queries my swissdamed device entry?

Under hourly billing, every hour is billed. Under reg-plus-annual, query responses are sometimes inside scope and sometimes billed separately. Under Pure Global's flat-fee model, query responses are inside the annual fee. Confirm this in writing.

Will the future swissdamed device registration fee make Switzerland substantially more expensive?

Unlikely to be material at the per-device level. Swissmedic's existing per-notification fee is CHF 300, and the swissdamed fee is widely expected to land in a similar range. Pure Global's flat fee insulates buyers from CH-REP-side workload uncertainty regardless of how Swissmedic resolves the fee.

Does my Class I device need a CH-REP?

Yes, if the manufacturer is non-Swiss. Class I self-declared devices are not exempt from CH-REP requirements; they are only exempt from EU Notified Body involvement.

How does CH-REP cost compare to other major markets?

Switzerland's CH-REP cost ($2,000–$4,000/year flat fee for 1–5 devices) sits in line with EU EC-REP and UK Responsible Person markets and is well below Japan's DMAH or China's NMPA Agent. See Medical Device Registration Cost by Country: 2026 Global Comparison.

Can I negotiate the flat-fee price?

The published rate is the rate. Negotiable variables are typically scope (number of devices, contract length). For 6+ device portfolios, custom pricing applies.

Bottom Line

Swissmedic government fees are not where Swiss budgets get blown up — they are modest today and will remain so after the July 2026 swissdamed deadline finalizes a per-device fee. The line that wrecks budgets is the CH-REP service fee, specifically when those fees hit. Hourly front-loads 50–60% of 3-year cost into Year 1. Reg-plus-annual front-loads 40–50% and re-prices the July 2026 swissdamed entry as a separate event. Flat all-inclusive billing flattens the curve to ~33% per year and absorbs the July 2026 transition at zero incremental cost.

The numbers are 2026 benchmarks. The pricing model questions are timeless. Ask them before you sign.

Related Guides

• Switzerland Swissmedic Medical Device Registration Guide (2026)
• EU MDR Medical Device Registration: The Complete Guide
• Medical Device Registration Cost by Country: 2026 Global Comparison
• Medical Device Regulatory Consulting Hourly Rates by Region